Data / Form D filings / Fedora Pharmaceuticals Inc.
Fedora Pharmaceuticals Inc.: Form D filings
Fedora Pharmaceuticals Inc., a pharmaceuticals company in Edmonton, Alberta, Canada, filed 2 Form D notices with the SEC between 2013 and 2025. The latest, on June 6, 2025, reports $895,076 sold of a $7.2 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11629 105 AVENUE NW, Edmonton, Alberta, Canada, T5H 0
- Phone
- (708) 761-0561
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Alberta, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1576423
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | New notice | $7,239,326 | $895,076 | $6,344,250 | 10 | Apr 25, 2025 | sec.gov |
| May 10, 2013 | New notice | $200,100 | $200,100 | 1 | Apr 22, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sarat Maharaj | Director | |
| Christopher Micetich | Executive Officer, Director | |
| Leonard Post | Director |
Every Form D from the week of Jun 2, 2025 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Fedora Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.